WFDC2 and Miyoshi myopathy: Importantly, serum levels of MM-associated pro-tumorigenic factors such as GDF15, CSF1, suPAR, and HE4 did not change after ASCT comparing to sample at the diagnosis (Supplementary Table S2D).